United States · Series A startup

Who invested in Embleema

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Web3 & Crypto

Funding summaryUpdated 26 Oct 2026

$3.7Mraised across 1 round since 2019, from 1 source

Latest round
Series A, $3.7MFeb 2019
Investors
2
See who backed them

The rounds

  1. Feb 2019
    Series A$3.7M

    Reported by FinSMEsSEC filing: $3.0M sold, first sale Jan 2019

Founders and team

From Embleema's own website and the SEC filings it signed: 3 founders, 5 on the team.

Robert ChuCEO & Co-FounderNamed on its 2019 Form D
Nicolas SchmidtChief Product Officer & Co-Founder
Braden RoyerFounding Account Executive
  • Aaron SmithHead of Clinical Operations
  • Tim EvainVP of Engineering
  • Alana MatosLead Product Designer
  • Job OpeningsPartner with us
  • Naira StepanyanClient Success Manager

On the board, as filediRoman Martens

Everyone who backed them

TechstarsVC firm1round
PharmagestVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Embleema

Who invested in Embleema?

Embleema's investors include Techstars and Pharmagest.

How much has Embleema raised?

Embleema has raised $3.7M across 1 round since 2019.

When did Embleema last raise?

Embleema's most recent round was a Series A of $3.7M in Feb 2019.

What was Embleema's biggest round?

Its most recent round, $3.7M in Feb 2019, is also its largest on record.

Who backed Embleema first?

Embleema's first round on record, in Feb 2019, was backed by Techstars and Pharmagest.

What stage is Embleema at?

Embleema's latest named round is a Series A, in Feb 2019.

Where is Embleema based?

Embleema is based in the United States.

Companies like Embleema

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.